Literature DB >> 7690673

Modulation of calcium-dependent and -independent components of veratridine-evoked release of glutamate from rat cerebellum.

B G Dickie1, J A Davies.   

Abstract

The entry of Ca2+ into the presynaptic neuronal terminal is considered to be a prerequisite for exocytosis. However, reports suggest that a Ca(2+)-independent component of release can exist for some neurotransmitters. In this study we have used veratridine-stimulated release of glutamate from rat cerebellar slices to investigate Ca(2+)-dependent and -independent release. A 1-min pulse of veratridine (10 microM) induced release of glutamate in both Ca(2+)-replete and Ca(2+)-free ACSF. Both modes of release, however, could be elicited in a sequential manner following a single application of veratridine in Ca(2+)-free ACSF, with return to Ca(2+)-replete conditions 5 min post-pulse. This separation permitted the modulation of either, or both, phases of release. Apamin and dihydrokainate had little effect on Ca(2+)-independent release but produced enhancement of the Ca(2+)-dependent phase. Tetrodotoxin abolished both phases of release when applied with the veratridine pulse, but had no effect on the Ca(2+)-dependent phase alone. The Ca(2+)-dependent phase was partially sensitive to Co2+, although the Ca2+ channel blockers verapamil, amiloride, omega-conotoxin and ruthenium red were ineffective, suggesting a lack of involvement of L-, N- or T-type channels. The possible mechanisms mediating the Ca(2+)-dependent and -independent components of endogenous glutamate release from cerebellar slices are discussed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7690673     DOI: 10.1016/0006-8993(93)91618-3

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  1 in total

1.  Potassium channel activators decrease endogenous glutamate release from rat cerebellar slices.

Authors:  B G Dickie; J A Davies
Journal:  Amino Acids       Date:  1995-06       Impact factor: 3.520

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.